Plexus Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Plexus stock.
View analyst ratings for Plexus or view top-rated stocks.

3 brokerages have issued 1 year price targets for Plexus' stock. Their PLXS stock forecasts range from $90.00 to $110.00. On average, they predict Plexus' share price to reach $100.00 in the next twelve months. This suggests a possible upside of 28.6% from the stock's current price.
View analysts' price targets for Plexus or view top-rated stocks among Wall Street analysts.

Plexus' stock was trading at $95.89 on January 1st, 2022. Since then, PLXS shares have decreased by 18.9% and is now trading at $77.77.
View the best growth stocks for 2022 here.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Plexus.

Plexus will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Plexus Corp. (NASDAQ:PLXS) posted its earnings results on Wednesday, April, 27th. The technology company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.83 by $0.12. The technology company earned $888.70 million during the quarter, compared to analysts' expectations of $839.76 million. Plexus had a net margin of 3.31% and a trailing twelve-month return on equity of 11.05%. Plexus's revenue was up .9% on a year-over-year basis. During the same quarter last year, the firm posted $1.49 EPS.
View Plexus' earnings history.

80 employees have rated Plexus CEO Todd Kelsey on Glassdoor.com. Todd Kelsey has an approval rating of 77% among Plexus' employees.

Some companies that are related to Plexus include Trimble (TRMB), Jabil (JBL), IPG Photonics (IPGP), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), Methode Electronics (MEI), TTM Technologies (TTMI), CTS (CTS), Benchmark Electronics (BHE), Park Aerospace (PKE), Neonode (NEON) and Key Tronic (KTCC).
View all of PLXS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Pfizer (PFE), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM), Teledyne FLIR (FLIR), First Solar (FSLR) and Gilead Sciences (GILD).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PLXS stock can currently be purchased for approximately $77.77.

Plexus (NASDAQ:PLXS) has a market capitalization of $2.16 billion and generates $3.37 billion in revenue each year. The technology company earns $138.91 million in net income (profit) each year or $3.88 on an earnings per share basis.

Plexus employs 19,200 workers across the globe.

Plexus was founded in 1979.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The official website for Plexus is www.plexus.com. The technology company can be reached via phone at (920) 969-6000, via email at heather.beresford@plexus.com, or via fax at 920-751-5395.